- Research works
- 85 ▲ 21% vs 2013–17
- Citations
- 2.6k 30.4 per fractional work
- Top-10% rate
- 5.6% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Agendia (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 10.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 10.3×
- Economics, Econometrics and Finance 3.0×
- Medicine 1.6×
- Immunology and Microbiology 1.1×
- Health Professions 0.6×
- Chemistry 0.2×
- Engineering 0.2×
- Earth and Planetary Sciences 0.1×
- Business, Management and Accounting 0.1×
- Environmental Science 0.1×
- Social Sciences 0.0×
Who are the top researchers at Agendia (Netherlands)?
Ranked on the composite score, Annuska M. Glas and William Audeh lead among researchers whose main affiliation is Agendia (Netherlands).
- 1 Annuska M. Glas Netherlands · #284,755 worldwide 107 citations · 30 works
- 2 William Audeh Netherlands · #1,404,912 worldwide 21 citations · 15 works
Which keywords describe research at Agendia (Netherlands)?
By fractional works in all years, weighted toward what it does more of than the world: Gene Expression, Molecular Subtypes, Clinical Practice Guidelines, Radiotherapy, Neoadjuvant Therapy, Survival Analysis, Prognostic Markers and Breast Tumours.
- Immunohistochemistry
- BRCA2
- Molecular Profiling
- Adjuvant Chemotherapy
- HER2
- Differential Expression
- Real-Time PCR
- Cancer
- CDK4/6 Inhibitors
- Metastatic Breast Cancer
- Cancer Risk
- Mutational Signatures
- Precision Medicine
- Genomic Instability
- Normalization
- Breast Cancer
- Breast Tumours
- Prognostic Markers
- Radiotherapy
- Molecular Subtypes
- Gene Expression
- Clinical Practice Guidelines
- Neoadjuvant Therapy
- Survival Analysis
- Treatment Response
- Data Analysis
- Targeted Therapy
- Chemotherapy
- Cancer Genomics
- Machine Learning
- Genetic Testing
- Cell Cycle Control
- Palbociclib
- Quantitative
- Reference Genes
- Microarray
- Trastuzumab
- Metastasis
- BRCA1
- Gene Expression Profiling
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Gene Expression30▲ 56×7 topics
- Molecular Subtypes22▲ 296×3 topics
- Clinical Practice Guidelines21▲ 45×6 topics
- Radiotherapy21▲ 65×4 topics
- Neoadjuvant Therapy21▲ 110×3 topics
- Prognostic Markers21▲ 254×2 topics
- Survival Analysis21▲ 89×3 topics
- Breast Tumours20▲ 483×1 topic
- Treatment Response20▲ 483×1 topic
- Breast Cancer15▲ 62×9 topics
- Data Analysis8▲ 27×2 topics
- Normalization8▲ 122×2 topics
- Targeted Therapy7▲ 37×3 topics
- Genomic Instability7▲ 61×2 topics
- Chemotherapy6▲ 11×9 topics
- Precision Medicine6▲ 24×4 topics
- Cancer Genomics6▲ 133×1 topic
- Mutational Signatures6▲ 133×1 topic
- Machine Learning6▲ 3.1×4 topics
- Cancer Risk5▲ 25×3 topics
- Genetic Testing5▲ 39×2 topics
- Metastatic Breast Cancer5▲ 93×2 topics
- Cell Cycle Control5▲ 227×2 topics
- CDK4/6 Inhibitors5▲ 344×1 topic
- Palbociclib5▲ 344×1 topic
- Cancer4▲ 3.7×14 topics
- Quantitative4▲ 42×2 topics
- Real-Time PCR4▲ 107×1 topic
- Reference Genes4▲ 107×1 topic
- Differential Expression4▲ 145×1 topic
- Microarray4▲ 145×1 topic
- HER23▲ 130×1 topic
- Trastuzumab3▲ 92×1 topic
- Adjuvant Chemotherapy3▲ 48×2 topics
- Metastasis3▲ 10×5 topics
- Molecular Profiling3▲ 30×3 topics
- BRCA13▲ 131×1 topic
- BRCA23▲ 131×1 topic
- Gene Expression Profiling3▲ 34×2 topics
- Immunohistochemistry3▲ 35×3 topics
Which research topics does Agendia (Netherlands) publish most on?
By volume in 2022–2025: Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research and Molecular Biology Techniques and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Breast Cancer Treatment Studies Cancer Research 4 works
- 2 Cancer Genomics and Diagnostics Cancer Research 2 works
- 3 HER2/EGFR in Cancer Research Oncology 1 works
- 4 Molecular Biology Techniques and Applications Molecular Biology 1 works
- 5 BRCA gene mutations in cancer Genetics 1 works
- 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 7 Innovation Policy and R&D Economics and Econometrics 0 works
- 8 Gene expression and cancer classification Molecular Biology 0 works
- 9 Cancer Cells and Metastasis Oncology 0 works
- 10 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Agendia (Netherlands)'s research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Amsterdam
- University of Amsterdam
- Vrije Universiteit Amsterdam
- Amsterdam UMC Location University of Amsterdam
- Amsterdam UMC Location Vrije Universiteit Amsterdam
- Philips (Netherlands)
- Amsterdam University Medical Centers
- Centrum Wiskunde & Informatica
- Institute for Atomic and Molecular Physics
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.